GSK plc announced the purchase of 462,000 ordinary shares at prices between 2,184.00p and 2,213.00p on February 23, 2026, as part of their ongoing buyback program. They have now bought 2,229,000 shares since February 17, 2026, and will hold a total of 242,120,094 shares as treasury stock.